DexCom Inc (DXCM) — Cash Flow Reinvestment Rate
DexCom Inc (DXCM) has a Cash Flow Reinvestment Rate of 0.57x as of March 2026, reinvesting $298.50 Million (capex $76.60 Million plus investments $-221.90 Million) from operating cash flow of $525.60 Million. See how much free cash does DexCom Inc generate to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
DexCom Inc Cash Flow Reinvestment Rate (2013–2025)
Historical reinvestment intensity for DexCom Inc across 13 annual periods. For the full cash flow conversion analysis, see DXCM operating cash flow.
Annual Cash Flow Reinvestment Rate for DexCom Inc (2013–2025)
Year-by-year capital reinvestment analysis for DexCom Inc. See financial flexibility index of DexCom Inc to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (USD) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.88x | $1.26 Billion | $1.44 Billion | $363.50 Million | ▲ +53.1% |
| 2024 | 0.57x | $566.30 Million | $989.50 Million | $358.80 Million | ▼ -68.3% |
| 2023 | 1.81x | $1.35 Billion | $748.50 Million | $236.60 Million | ▲ +140.4% |
| 2022 | 0.75x | $503.30 Million | $669.50 Million | $364.80 Million | ▼ -42.9% |
| 2021 | 1.32x | $582.40 Million | $442.50 Million | $389.20 Million | ▼ -37.8% |
| 2020 | 2.12x | $1.01 Billion | $475.60 Million | $199.00 Million | ▼ -34.4% |
| 2019 | 3.23x | $1.02 Billion | $314.50 Million | $180.00 Million | ▲ +209.5% |
| 2018 | 1.04x | $128.50 Million | $123.20 Million | $67.10 Million | ▼ -33.5% |
| 2017 | 1.57x | $144.40 Million | $92.00 Million | $66.00 Million | ▲ +57.0% |
| 2016 | 1.00x | $56.20 Million | $56.20 Million | $55.70 Million | ▼ -3.9% |
| 2015 | 1.04x | $51.00 Million | $49.00 Million | $33.30 Million | ▲ +46.2% |
| 2014 | 0.71x | $16.80 Million | $23.60 Million | $16.20 Million | ▼ -95.3% |
| 2013 | 15.29x | $36.70 Million | $2.40 Million | $7.90 Million | — |